View of EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY

Return to Article Details EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY Download Download PDF